Delivery Order 75N93018D00008-75N93022F00002
Award Date
5/1/22
Potential Completion Date
11/1/22
Potential Value
$218K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Curia Global Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
West Menlo Park, CA 94025, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Curia Global Inc. (doing business as Amri), a for-profit organization and manufacturer of goods. The award, valued at $610,340.86, is a delivery order under the Nonclinical Services for Development of Interventional Agents indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract directs Curia to prepare 400 grams of non-GMP (good manufacturing practice)...
This contract award is for Task Order C02 under the Nonclinical Services for Development of Interventional Agents master IDIQ contract, which was awarded to Curia Global Inc. (doing business as Amri), a global contract development and manufacturing organization (CDMO). The $542,766.00 cost-plus-fixed-fee task order was awarded on March 22, 2019 by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). This task order...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $443,000 delivery order against the Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity (IDIQ) multiple award contract to Curia Global Inc., doing business as Amri. This firm fixed price order is for non-clinical services and will be performed in Spain from September 14, 2022 through December...
This is a cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri). The order is for the completion of the synthesis of 400 grams of non-GMP (good manufacturing practice) antibiotic candidate FG-960-2. The total ceiling value of the order is $154,712.13, with a period of performance ending on January 30, 2021. This order is part of a larger...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $554,127.00 Cost Plus Fixed Fee contract to Curia Global Inc., doing business as Amri, for the "SCALE UP FERMENTATION AND ISOLATION OF MEDINAMYCIN" effort. This is a Delivery Order issued under the Nonclinical Services for Development of Interventional Agents indefinite-delivery, indefinite-quantity (IDIQ) contract. Curia Global is a leading global...
This federal contract award is for Task C03 under the Nonclinical Services for Development of Interventional Agents contract, a delivery order awarded to Curia Global Inc., doing business as Amri. Amri is a leading contract development and manufacturing organization (CDMO) that provides a wide range of pharmaceutical research and development services to federal agencies, particularly the National Institutes of Health (NIH) and its institutes. The award has a total ceiling value of $860,162.70...
This is a delivery order awarded to Curia Global Inc., doing business as Amri, by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The $662,706.10 cost-plus-fixed-fee contract is to provide chemistry and absorption/distribution/metabolism/excretion (ADMET) services in support of the Medicinal Chemistry Support Program (MCSP) and other NIH initiatives related to neurology, infectious diseases, and...
This federal contract award to Curia Global Inc., doing business as AMRI, is for chemistry and manufacturing services related to the chemical synthesis and process optimization of the compound STF-1759. The award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract has a ceiling value of $411,404.73 and a period of performance through September 30, 2021. It is a cost-plus-fixed-fee...
This is a $3,453,835.19 delivery order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc., doing business as Amri, a for-profit manufacturer. The contract is for the Medicinal Chemistry Support Program for Therapeutic Development, which provides chemistry, manufacturing, and controls development; exploratory chemistry; hit-to-lead chemistry;...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $1,056,500 delivery order to Curia Global Inc., doing business as Amri, under the prime contractor's Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity master contract. The delivery order is for the manufacture of MBX-400, with work to be performed by Amri in Albany, New York between...